Cite
HARVARD Citation
Sayal, K. et al. (n.d.). Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study. International journal of gynecological cancer. 25 (6), pp. 977-984. [Online].